Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

BCL7B antibody

The Rabbit Polyclonal anti-BCL7B antibody has been validated for WB, ELISA and IHC. It is suitable to detect BCL7B in samples from Human, Mouse and Rat.
Catalog No. ABIN7111913

Quick Overview for BCL7B antibody (ABIN7111913)

Target

See all BCL7B Antibodies
BCL7B (B-Cell CLL/lymphoma 7B (BCL7B))

Reactivity

Human, Mouse, Rat

Host

  • 28
  • 3
Rabbit

Clonality

  • 29
  • 2
Polyclonal

Conjugate

  • 12
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This BCL7B antibody is un-conjugated

Application

  • 30
  • 13
  • 12
  • 10
  • 5
  • 1
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
  • Purification

    Immunogen affinity purified

    Purity

    ≥95 % as determined by SDS-PAGE

    Immunogen

    B-cell CLL/lymphoma 7B

    Isotype

    IgG
  • Application Notes

    WB: 1:500-1:2000, IHC: 1:20-1:200

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C

    Storage Comment

    -20°C for 12 months (Avoid repeated freeze / thaw cycles.)

    Expiry Date

    12 months
  • Target

    BCL7B (B-Cell CLL/lymphoma 7B (BCL7B))

    Alternative Name

    BCL7B

    Background

    Synonyms: Background:Positive regulator of apoptosis. Plays a role in the Wnt signaling pathway, negatively regulating the expression of Wnt signaling components CTNNB1 and HMGA1(PubMed:25569233). Involved in cell cycle progression, maintenance of the nuclear structure and stem cell differentiation(PubMed:25569233). May play a role in lung tumor development or progression(By similarity).

    Molecular Weight

    45 kDa

    Gene ID

    9275

    UniProt

    Q9BQE9
You are here:
Chat with us!